QIAGEN, Incyte Team Up for CALR MPNs Companion Diagnostics
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) today announced a new global collaboration to develop a novel diagnostic panel to...
Tag : gene therapy development
AviadoBio Launches ASPIRE-FTD Phase 1/2 Trial in the UK
– AVB-101 is an investigational one-time therapy designed to deliver a functional copy of the GRN gene directly to the brain, thereby potentially restoring progranulin levels...